Isatuximab (Sarclisa) with bortezomib, lenalidomide, and dexamethasone (VRd) is now an approved option for adults who cannot ...

The FDA approved isatuximab plus bortezomib, lenalidomide, and dexamethasone for patients with newly diagnosed myeloma who ...

During a Case-Based Roundtable® event, Andrzej Jakubowiak, MD, PhD, discussed 2 recent trials in multiple myeloma for ...

The Food and Drug Administration (FDA) has approved Sarclisa (isatuximab-irfc) with Velcade (bortezomib), Revlimid ...

Sanofi has claimed FDA approval for its anti-CD38 drug isatuximab as a third-line treatment for multiple myeloma, becoming the first direct rival to Johnson & Johnson’s big-selling Darzalex.

Describes the nature of a clinical study. Types include: Observational study — observes people and measures outcomes without affecting results. Interventional study (clinical trial) — studies new ...

Describes the nature of a clinical study. Types include: Observational study — observes people and measures outcomes without affecting results. Interventional study (clinical trial) — studies new ...

South San Franciso, California Friday, September 6, 2024, 16:30 Hrs [IST] ...

The militant group targeted areas in Israel farther south than most of its previous attacks, reinforcing fears of broader regional conflict. For Middle Eastern Foes, Diplomacy Takes a Back Seat to ...

Darzalex Faspro can also cause reactions at the injection site, such as swelling, itching, and redness. Isatuximab is another monoclonal antibody that attaches to the CD38 protein on myeloma cells.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

The approval is supported by data from the phase 3 IMROZ study which demonstrated superior progression-free survival with ...